Provided by Tiger Fintech (Singapore) Pte. Ltd.

Ultragenyx Pharmaceutical

37.49
-1.8000-4.58%
Post-market: 37.490.00000.00%16:44 EDT
Volume:1.09M
Turnover:41.22M
Market Cap:3.54B
PE:-6.38
High:39.33
Open:38.34
Low:37.13
Close:39.29
Loading ...

BRIEF-Ultragenyx reports inducement grant under Nasdaq listing rule 5635(C)(4)

Reuters
·
20 Mar

Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)

THOMSON REUTERS
·
20 Mar

Watch Out: 23 Altcoins Have Massive Token Unlocks in the New Week – Here’s the Day-by-Day, Hour-by-Hour List

CoinMarketCap
·
17 Mar

SuperRare (RARE) Climbs 50%, But Correction Risks Increase

BE[IN]CRYPTO
·
11 Mar

Ultragenyx Pharmaceutical (RARE) Gets a Buy from J.P. Morgan

TIPRANKS
·
08 Mar

Ultragenyx Pharmaceutical: Strong Buy Rating Backed by Growth Potential and Robust Pipeline

TIPRANKS
·
07 Mar

NYSE CONTENT ADVISORY: PRE-MARKET UPDATE + RARE DISEASE DAY AWARENESS

PR Newswire
·
28 Feb

Ultragenyx Pharma Price Target Maintained With a $118.00/Share by Cantor Fitzgerald

Dow Jones
·
26 Feb

Ultragenyx to Participate at Investor Conferences in March

GlobeNewswire
·
25 Feb

Analysts Offer Insights on Healthcare Companies: Icon (ICLR), Pediatrix Medical Group (MD) and Ultragenyx Pharmaceutical (RARE)

TIPRANKS
·
23 Feb

Exploring Three High Growth Tech Stocks in the United States

Simply Wall St.
·
22 Feb

BRIEF-Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)

Reuters
·
20 Feb

Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)

THOMSON REUTERS
·
20 Feb

Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire
·
20 Feb

Ultragenyx Pharma Price Target Maintained With a $95.00/Share by HC Wainwright & Co.

Dow Jones
·
19 Feb

Optimistic Outlook for Ultragenyx Pharmaceutical Amid Promising Gene Therapy Developments

TIPRANKS
·
19 Feb

Ultragenyx Pharmaceutical Shares up 1.7% as FDA Accepts Genetic Disorder Therapy for Review

THOMSON REUTERS
·
19 Feb

Ultragenyx Pharmaceutical Eyes Aug. 18 FDA Approval for Sanfilippo Syndrome Gene Therapy Treatment

MT Newswires Live
·
18 Feb

Ultragenyx’s BLA for UX111 accepted by FDA for priority review

TIPRANKS
·
18 Feb

Ultragenyx Pharmaceutical Inc - FDA Not Planning Advisory Committee Meeting for Ultragenyx Bla

THOMSON REUTERS
·
18 Feb